Thyroid hormone dependent regulation of target genes and their physiological significance

Chang Gung Medical Journal

Volumn 31, Issue 4, 2008, Pages 325-334

  Huang, Ya Hui ^a   Tsai, Ming Ming ^b   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Coagulation; Receptor; Regulation; Thyroid hormone; Transcription

Indexed keywords

APOLIPOPROTEIN; COMPLEMENTARY DNA; CYCLOHEXIMIDE; FIBRINOGEN; FIBRONECTIN; LIOTHYRONINE; PROTEIN ARA70; PROTEIN SULT2A1; REGULATOR PROTEIN; STEROIDOGENIC FACTOR 1; THYROID HORMONE RECEPTOR ALPHA; TRANSFERRIN;

BLOOD CLOTTING; CARCINOMA CELL; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA MICROARRAY; DRUG MECHANISM; GENE EXPRESSION; GENE ISOLATION; GENE MUTATION; GENE TARGETING; GENETIC TRANSCRIPTION; HEPATOMA CELL; HORMONAL REGULATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INFLAMMATION; LIVER CELL CARCINOMA; METABOLISM; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERTOLI CELL; TUMOR CELL LINE; UPREGULATION;

ANIMALS; APOLIPOPROTEINS; CELL PROLIFERATION; FIBRINOGEN; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; ONCOGENE PROTEINS; PHOSPHORYLATION; RECEPTORS, THYROID HORMONE; SULFOTRANSFERASES; THYROID HORMONES; TRANSCRIPTION FACTORS; TRANSFERRIN;

EID: 48749096298     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Koenig RJ. Thyroid hormone receptor coactivators and corepressors. Thyroid 1998;8:703-13.
2. Kountouras J, Lygidakis NJ. New epidemiological data on liver oncogenesis. Hepatogastroenterology 2000;47:855-61.
3. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 1993;14:184-93.
4. Lazar MA. When is a thyroid hormone receptor not a thyroid hormone receptor? Endocrinology 1996;137:4071-2.
5. Lee JW, Chen JY, Yang CS, Doong SL. Thyroid hormone receptor alpha 1 (c-erb A alpha 1) suppressed transforming phenotype of nasopharyngeal carcinoma cell line. Cancer Lett 2002;184:149-56.
6. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986;324:635-40.
7. Samuels HH, Forman BM, Horowitz ZD, Ye ZS. Regulation of gene expression by thyroid hormone. J Clin Invest 1988;81:957-67.
8. Thormeyer D, Baniahmad A. The v-erbA oncogene (review). Int J Mol Med 1999;4:351-8.
9. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986;324:641-6.
10. Wu Y, Koenig RJ. Gene regulation by thyroid hormone. Trends Endocrinol Metab 2000;11:207-11.
11. Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol 2000;62:439-66.
12. Apriletti JW, Ribeiro RC, Wagner RL, Feng W, Webb P, Kushner PJ, West BL, Nilsson S, Scanlan TS, Fletterick RJ, Baxter JD. Molecular and structural biology of thyroid hormone receptors. Clin Exp Pharmacol Physiol Suppl 1998;25:S2-11.
13. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269-304.
14. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097-142.
15. Cheng SY. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 2000;1:9-18.
16. Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev Camb Philos Soc 2000;75:519-631.
17. Cheng Sy. New insights into the structure and function of the thyroid hormone receptor. J Biomed Sci 1995;2:77-89.
18. Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ, Stallcup MR. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 1998;12:302-13.
19. Li D, Yamada T, Wang F, Vulin AI, Samuels HH. Novel roles of retinoid X receptor (RXR) and RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer. J Biol Chem 2004;279:7427-37.
20. Jeyakumar M, Liu XF, Erdjument-Bromage H, Tempst P, Bagchi MK. Phosphorylation of thyroid hormone receptor-associated nuclear receptor corepressor holocomplex by the DNA-dependent protein kinase enhances its histone deacetylase activity. J Biol Chem 2007;282:9312-22.
21. Furuya F, Ying H, Zhao L, Cheng SY. Novel functions of thyroid hormone receptor mutants: Beyond nucleus-initiated transcription. Steroids 2007;72:171-9.
22. Diallo EM, Wilhelm KG, Jr, Thompson DL, Koenig RJ. Variable RXR requirements for thyroid hormone responsiveness of endogenous genes. Mol Cell Endocrinol 2007;264:149-56.
23. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997;389:194-8.
24. Jenster G, Spencer TE, Burcin MM, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci USA 1997;94:7879-84.
25. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW. Role of co-activators and corepressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 1997;52:141-64; discussion 64-5.
26. Wu Y, Kawate H, Ohnaka K, Nawata H, Takayanagi R. Nuclear compartmentalization of N-CoR and its interactions with steroid receptors. Mol Cell Biol 2006;26:6633-55.
27. Peterson TJ, Karmakar S, Pace MC, Gao T, Smith CL. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Mol Cell Biol 2007;27:5933-48.
28. Li J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. Embo J 2000;19:4342-50.
29. Bassett JH, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 2003;213:1-11.
30. Davis PJ, Davis FB, Cody V. Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 2005;16:429-35.
31. Chen SL, Chang YJ, Wu YH, Lin KH. Mitogen-activated protein kinases potentiate thyroid hormone receptor transcriptional activity by stabilizing its protein. Endocrinology 2003;144:1407-19.
32. Chamba A, Neuberger J, Strain A, Hopkins J, Sheppard MC, Franklyn JA. Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver. J Clin Endocrinol Metab 1996;81:360-7.
33. Chang C, Lin Y, TW OL, Chou CK, Lee TS, Liu TJ, P'Eng F K, Chen TY, Hu CP. Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol 1983;3:1133-7.
34. Weitzel JM, Radtke C, Seitz HJ. Two thyroid hormone-mediated gene expression patterns in vivo identified by cDNA expression arrays in rat. Nucleic Acids Res 2001;29:5148-55.
35. Shoemaker DD, Linsley PS. Recent developments in DNA microarrays. Curr Opin Microbiol 2002;5:334-7.
36. Loosfelt H, Atger M, Misrahi M, Guiochon-Mantel A, Meriel C, Logeat F, Benarous R, Milgrom E. Cloning and sequence analysis of rabbit progesterone-receptor complementary DNA. Proc Natl Acad Sci USA 1986;83:9045-9.
37. Jenkins ES, Broadhead C, Combes RD. The implications of microarray technology for animal use in scientific research. Altern Lab Anim 2002;30:459-65.
38. Feng X, Jiang Y, Meltzer P, Yen PM. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol 2000;14:947-55.
39. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 2004;145:2804-14.
40. Kakafika AI, Liberopoulos EN, Mikhailidis DP. Fibrinogen: a predictor of vascular disease. Curr Pharm Des 2007;13:1647-59.
41. Vu D, Neerman-Arbez M. Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins. J Thromb Haemost 2007;5 Suppl 1:125-31.
42. Di Cera E. Thrombin as procoagulant and anticoagulant. J Thromb Haemost 2007;5 Suppl 1:196-202.
43. Herrick S, Blanc-Brude O, Gray A, Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999;31:741-6.
44. Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci 2001;936:406-25.
45. Burggraaf J, Lalezari S, Emeis JJ, Vischer UM, de Meyer PH, Pijl H, Cohen AF. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001;11:153-60.
46. Lin KH, Shieh HY, Hsu HC. Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 2000;141:2540-7.
47. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-4.
48. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME. Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 1988;48:6550-4.
49. Andrews NC. Iron metabolism: iron deficiency and iron overload. Annu Rev Genomics Hum Genet 2000;1:75-98.
50. Barnum-Huckins K, Adrian GS. Iron regulation of transferrin synthesis in the human hepatoma cell line HepG2. Cell Biol Int 2000;24:71-7.
51. Chen LH, Bissell MJ. Transferrin mRNA level in the mouse mammary gland is regulated by pregnancy and extracellular matrix. J Biol Chem 1987;262:17247-50.
52. Eby JE, Sato H, Sirbasku DA. Apotransferrin stimulation of thyroid hormone dependent rat pituitary tumor cell growth in serum-free chemically defined medium: role of FE(III) chelation. J Cell Physiol 1993;156:588-600.
53. Feelders RA, Kuiper-Kramer EP, van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med 1999;37:1-10.
54. Leedman PJ, Stein AR, Chin WW, Rogers JT. Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J Biol Chem 1996;271:12017-23.
55. Lin KH, Lee HY, Shih CH, Yen CC, Chen SL, Yang RC, Wang CS. Plasma protein regulation by thyroid hormone. J Endocrinol 2003;179:367-77.
56. Webb P. Selective activators of thyroid hormone receptors. Expert Opin Investig Drugs 2004;13:489-500.
57. Baxter JD, Dillmann WH, West BL, Huber R, Furlow JD, Fletterick RJ, Webb P, Apriletti JW, Scanlan TS. Selective modulation of thyroid hormone receptor action. J Steroid Biochem Mol Biol 2001;76:31-42.
58. Oetting A, Yen PM. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 2007;21:193-208.
59. Taylor AH, Wishart P, Lawless DE, Raymond J, Wong NC. Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter. Biochemistry 1996;35:8281-8.
60. Ruoslahti E. Fibronectin and its alpha 5 beta 1 integrin receptor in malignancy. Invasion Metastasis 1994;14:87-97.
61. Cho J, Mosher DF. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 2006;4:1461-9.
62. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002;115:3861-3.
63. Lin KH, Chen CY, Chen SL, Yen CC, Huang YH, Shih CH, Shen JJ, Yang RC, Wang CS. Regulation of fibronectin by thyroid hormone receptors. J Mol Endocrinol 2004;33:445-58.
64. Chu XY, Huskey SE, Braun MP, Sarkadi B, Evans DC, Evers R. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3. J Pharmacol Exp Ther 2004;309:156-64.
65. Falany CN, Comer KA, Dooley TP, Glatt H. Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization. Ann N Y Acad Sci 1995;774:59-72.
66. Falany CN, Krasnykh V, Falany JL. Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. J Steroid Biochem Mol Biol 1995;52:529-39.
67. Falany JL, Krasnykh V, Mikheeva G, Falany CN. Isolation and expression of an isoform of rat estrogen sulfotransferase. J Steroid Biochem Mol Biol 1995;52:35-44.
68. Falany CN. Enzymology of human cytosolic sulfotransferases. FASEB J 1997;11:206-16.
69. Falany CN. Sulfation and sulfotransferases. Introduction: changing view of sulfation and the cytosolic sulfotransferases. FASEB J 1997;11:1-2.
70. Falany JL, Falany CN. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells. Oncol Res 1997;9:589-96.
71. Falany JL, Macrina N, Falany CN. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 2004;88:383-91.
72. Nagata K, Yamazoe Y. Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol 2000;40:159-76.
73. Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA, Runge-Morris M. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 2002;30:997-1004.
74. Chen X, Baker SM, Chen G. Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells. J Appl Toxicol 2005;25:354-60.
75. Chen G, Zhang D, Jing N, Yin S, Falany CN, Radominska-Pandya A. Human gastrointestinal sulfotransferases: identification and distribution. Toxicol Appl Pharmacol 2003;187:186-97.
76. Saner KJ, Suzuki T, Sasano H, Pizzey J, Ho C, Strauss JF, 3rd, Carr BR, Rainey WE. Steroid sulfotransferase 2A1 gene transcription is regulated by steroidogenic factor 1 and GATA-6 in the human adrenal. Mol Endocrinol 2005;19:184-97.
77. Huang YH, Lee CY, Tai PJ, Yen CC, Liao CY, Chen WJ, Liao CJ, Cheng WL, Chen RN, Wu SM, Wang CS, Lin KH. Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones. Endocrinology 2006;147:2481-9.
78. Tagawa N, Tamanaka J, Fujinami A, Kobayashi Y, Takano T, Fukata S, Kuma K, Tada H, Amino N. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin Chem 2000;46:523-8.
79. Alen P, Claessens F, Schoenmakers E, Swinnen JV, Verhoeven G, Rombauts W, Peeters B. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol 1999;13:117-28.
80. Gao T, Brantley K, Bolu E, McPhaul MJ. RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays. Mol Endocrinol 1999;13:1645-56.
81. Hsiao PW, Chang C. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells. J Biol Chem 1999;274:22373-9.
82. Lanzino M, De Amicis F, McPhaul MJ, Marsico S, Panno ML, Ando S. Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells. J Biol Chem 2005;280:20421-30.
83. Lee P, Zhu CC, Sadick NS, Diwan AH, Zhang PS, Liu JS, Prieto VG. Expression of androgen receptor coactivator ARA70/ELE1 in androgenic alopecia. J Cutan Pathol 2005;32:567-71.
84. Lim HN, Hawkins JR, Hughes IA. Genetic evidence to exclude the androgen receptor co-factor, ARA70 (NCOA4) as a candidate gene for the causation of under-masculinised genitalia. Clin Genet 2001;59:284-6.
85. Miyoshi Y, Ishiguro H, Uemura H, Fujinami K, Miyamoto H, Kitamura H, Kubota Y. Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer. Prostate 2003;56:280-6.
86. Nishizuka M, Tsuchiya T, Nishihara T, Imagawa M. Induction of Bach1 and ARA70 gene expression at an early stage of adipocyte differentiation of mouse 3T3-L1 cells. Biochem J 2002;361:629-33.
87. Tekur S, Lau KM, Long J, Burnstein K, Ho SM. Expression of RFG/ELE1alpha/ARA70 in normal and malignant prostatic epithelial cell cultures and lines: regulation by methylation and sex steroids. Mol Carcinog 2001;30:1-13.
88. Tai PJ, Huang YH, Shih CH, Chen RN, Chen CD, Chen WJ, Wang CS, Lin KH. Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors. Endocrinology 2007;148:3485-95.
89. Yeh S, Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996;93:5517-21.
90. Arambepola NK, Bunick D, Cooke PS. Thyroid hormone effects on androgen receptor messenger RNA expression in rat Sertoli and peritubular cells. J Endocrinol 1998;156:43-50.
91. Lombardo F, Sgro P, Salacone P, Gilio B, Gandini L, Dondero F, Jannini EA, Lenzi A. Androgens and fertility. J Endocrinol Invest 2005;28:51-5.
92. Krassas GE, Pontikides N. Male reproductive function in relation with thyroid alterations. Best Pract Res Clin Endocrinol Metab 2004;18:183-95.
93. Esquenet M, Swinnen JV, Heyns W, Verhoeven G. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP. Mol Cell Endocrinol 1995;109:105-11.
94. Gong J, Ammanamanchi S, Ko TC, Brattain MG. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res 2003;63:3340-6.
95. Li CY, Suardet L, Little JB. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J Biol Chem 1995;270:4971-4.
96. Lents NH, Baldassare JJ. CDK2 and cyclin E knockout mice: lessons from breast cancer. Trends Endocrinol Metab 2004;15:1-3.
97. Martin-Castellanos C, Moreno S. Recent advances on cyclins, CDKs and CDK inhibitors. Trends in Cell Biol 1997;7:95-8.
98. Nielsen NH, Arnerlov C, Cajander S, Landberg G. Cyclin E expression and proliferation in breast cancer. Anal Cell Pathol 1998;17:177-88.
99. Nelsen CJ, Rickheim DG, Tucker MM, Hansen LK, Albrecht JH. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J Biol Chem 2003;278:3656-63.
100. Yen CC, Huang YH, Liao CY, Liao CJ, Cheng WL, Chen WJ, Lin KH. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. J Mol Endo 2006;36:9-21.
101. Barrera-Hernandez G, Park KS, Dace A, Zhan Q, Cheng SY. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 1999;140:5267-74.